LAB logo

Standard BioTools (LAB) Company Overview

Profile

Full Name:

Standard BioTools Inc.

Sector:

Healthcare

Country:

United States

IPO:

February 10, 2011

Indexes:

Not included

Description:

LAB (Standard BioTools) specializes in developing innovative tools and technologies for life sciences research. They provide advanced solutions for genomics, proteomics, and cell biology, helping scientists accelerate discoveries and improve healthcare outcomes. Their products support researchers in understanding complex biological systems more effectively.

Key Details

Price

$1.19

Annual Revenue

$174.43 M(+64.03% YoY)

Annual EPS

-$0.52(+44.68% YoY)

Annual ROE

-85.82%

Beta

1.72

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Feb 26, 2025

Recent annual earnings:

Feb 26, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 27, 25 Keybanc
Sector Weight
Oct 31, 24 TD Cowen
Buy
Aug 1, 24 TD Cowen
Buy
Apr 16, 24 TD Cowen
Buy
Apr 4, 24 Jefferies
Buy
Jul 12, 23 Keybanc
Overweight
Aug 27, 20 UBS
Buy
Aug 10, 20 UBS
Buy
Nov 6, 19 Janney Montgomery Scott
Neutral
Oct 18, 19 UBS
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Standard BioTools?
  • Does Standard BioTools pay dividends?
  • What sector is Standard BioTools in?
  • What industry is Standard BioTools in?
  • What country is Standard BioTools based in?
  • When did Standard BioTools go public?
  • Is Standard BioTools in the S&P 500?
  • Is Standard BioTools in the NASDAQ 100?
  • Is Standard BioTools in the Dow Jones?
  • When was Standard BioTools's last earnings report?
  • When does Standard BioTools report earnings?
  • Should I buy Standard BioTools stock now?

What is the ticker symbol for Standard BioTools?

The ticker symbol for Standard BioTools is NASDAQ:LAB

Does Standard BioTools pay dividends?

No, Standard BioTools does not pay dividends

What sector is Standard BioTools in?

Standard BioTools is in the Healthcare sector

What industry is Standard BioTools in?

Standard BioTools is in the Medical Devices industry

What country is Standard BioTools based in?

Standard BioTools is headquartered in United States

When did Standard BioTools go public?

Standard BioTools's initial public offering (IPO) was on February 10, 2011

Is Standard BioTools in the S&P 500?

No, Standard BioTools is not included in the S&P 500 index

Is Standard BioTools in the NASDAQ 100?

No, Standard BioTools is not included in the NASDAQ 100 index

Is Standard BioTools in the Dow Jones?

No, Standard BioTools is not included in the Dow Jones index

When was Standard BioTools's last earnings report?

Standard BioTools's most recent earnings report was on Feb 26, 2025

When does Standard BioTools report earnings?

The next expected earnings date for Standard BioTools is May 8, 2025

Should I buy Standard BioTools stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions